Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Patient Compliance 1Chronic Pain 1

Interventions

Fulvestrant 63Letrozole 53Paclitaxel 49Trastuzumab 41pembrolizumab 40ribociclib 37Specimen Handling 37palbociclib 36Capecitabine 34Carboplatin 33Anastrozole 33Tamoxifen 32exemestane 29pertuzumab 28abemaciclib 28Magnetic Resonance Spectroscopy 26Cyclophosphamide 26trastuzumab deruxtecan 24Surveys and Questionnaires 21Radiotherapy 18Biopsy 18olaparib 17Standard of Care 16Docetaxel 16Blood Specimen Collection 16Taxes 14Mastectomy, Segmental 14eribulin 13elacestrant 13130-nm albumin-bound paclitaxel 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Motivational Interviewing × 90 days × Clear all
NCT06635005 2026-05-11

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Completed
34 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT04730154 2026-05-06

BCS-PI

Universitair Ziekenhuis Brussel

Phase NA Active not recruiting
156 enrolled
Breast

Breast Neoplasms, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡